Recurrent pigmented macules after Q-switched alexandrite laser treatment of congenital melanocytic nevus

Dermatologic Surgery

Volumn 30, Issue 6, 2004, Pages 898-907

  Sohn, Seonghyang ^a   Kim, Sangeun ^a   Kang, Won Hyoung ^a   Chan, Henry H L ^b  

^a Ajou University School of Medicine   (South Korea)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA; UVOMORULIN;

ADOLESCENT; ADULT; ALEXANDRITE LASER; ARTICLE; ASIAN; CHILD; CLINICAL ARTICLE; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; KOREA; LASER; MALE; MELANOCYTE; MELANOCYTIC NEVUS; NEVUS; PRIORITY JOURNAL; Q SWITCHED ALEXANDRITE LASER; RECURRENT DISEASE; SKIN BIOPSY; SKIN PIGMENTATION; TREATMENT OUTCOME;

ADOLESCENT; ADULT; CADHERINS; CHILD; CHILD, PRESCHOOL; EAR, EXTERNAL; FACE; FEMALE; HUMANS; LASER THERAPY, LOW-LEVEL; LEG; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEVUS, PIGMENTED; SKIN NEOPLASMS; THORAX; TUMOR NECROSIS FACTOR-ALPHA;

EID: 2942640669     PISSN: 10760512     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1524-4725.2004.30258.x     Document Type: Article

References (31)

1. Rhodes AR, Silverman RA, Harrist TJ, Melski JW. A histologic comparison of congenital and acquired nevomelanocytic nevi. Arch Dermatol 1985;121:1266.
2. Goldberg DJ, Stampien T. Q-switched ruby laser treatment of congenital nevi. Arch Dermatol 1995;131-621-3.
3. Waldorf HA, Kauvar AN, Geronemus RG. Treatment of small and medium congenital nevi with the Q-switched ruby laser. Arch Dermatol 1996;132:301-4.
4. Grevelink JM, van Leeuwen RL, Anderson RR, Byers HR. Clinical and histological responseds of congenital melanocytic nevi after single treatment with Q-switched lasers. Arch Dermatol 1997;133:349-53.
5. Nelson JS, Kelly KM. Q-switched ruby laser treatment of a congenital melanocytic nevus. Dermatol Surg 1999;25:274-6.
6. Kono T, Nozaki M, Chan HH, Sasaki K, Kwon SG. Combined use of normal mode and Q switched ruby lasers in the treatment of congenital melanocytic naevi. Br J Plast Surg 2001;54:640-3.
7. Kono T, Ercocen AR, Chan HH, Kikuchi Y, Nozaki M. Effectiveness of the normal-mode ruby laser and the combined (normal-mode plus Q-switched) ruby laser in the treatment of congenital melanocytic nevi: a comparative study. Ann Plast Surg 2002;49:476-85.
8. Grevelink JM, van Leeuwen RL, Anderson RR, Byers R. Clinical and histological responses of congenital melanocytic nevi after single treatment with Q-switched lasers. Arch Dermatol 1997;133:349-53.
9. Park KH, Leonard DD, Arrington JH III, Lund HZ. Recurrent melanocytic nevi: clinical and histologic review of 175 cases. J Am Acad Dermatol 1987;17:285-92.
10. Eidelman S, Damsky CH, Wheelock MJ, Damjanov I. Expression of the cell-cell adhesion glycoprotein cell-CAM 120/80 in normal human tissues and tumors. Am J Pathol 1989;135:101-10.
11. Wheelock MJ, Jensen PJ. Regulation of keratinocyte intercellular junction organization and epidermal morphogenesis by E-cadherin. J Cell Biol 1992;117:415-25.
12. Tang A, Eller MS, Hara M, et al. E-cadherin is the major mediator of human melanocyte adhesion to keratinocytes in vitro. J Cell Sci 1994;107:983-92.
13. Kondo S. The roles of keratinocyte-derived cytokines in the epidermis and their possible responses to UVA irradiation. J Invest Dermatiol 1999;4:177-83.
14. Lee ES, Kim JH, Im S, et al. Application of computerized image analysis in pigmentary skin diseases. Int J Dermatol 2001;40:45-9.
15. Kornberg R, Ackerman AB. Pseudomelanoma: recurrent melanocytic nevus following partial surgical removal. Arch Dermatol 1975;111:1588.
16. van Leeuwen RL, Dekker SW, Byers HR, Vermeer BJ, Grevelink JM. Modulation of α4β1 and α5β1 integrin expression: heterogeneous effects of Q-switched ruby, Nd:YAG, and alexandrite lasers on melenoma cells in vitro. Lasers Surg Med 1996;18:63-71.
17. Chan HH, Xiang L, Leung JC, Tsang KW, Lai K. In vitro study examining the effect of sub-lethal QS 755nm lasers on the expression of p16INK4a on melanoma cell lines. Lasers Surg Med 2003;32:88-93.
18. Hoang MP, Prieto VG, Burchette JL, Shea CR. Recurrent melanocytic nevus: a histologic and immunohistochemical evaluation. J Cutan Pathol 2001;28:400-6.
19. Herlyn M, Berking C, Li G, Satyamoorthy K. Lessons from melanocyte development for understanding the biological events in naevus and melanoma formation. Melanoma Res 2000;10:303-11.
20. Takeichi M. Cadherin cell adhesion receptors as a morphogenetic regulator. Science 1991;251:1451-5.
21. Gumbiner BM, McCrea PD. Catenins as mediators of the cytoplasmic functions of cadherins. J Cell Sci 1993;17:155-8.
22. Ozawa M, Ringwald M, Kemler R. Uvomorulin-catenin complex formationis regulated by a specific domain in the cytoplasmic region of the cell adhesion molecule. Proc Natl Acad Sci USA 1990; 87:4246-50.
23. Hirano S, Kimoto N, Shimoyama Y, Hirohashi S, Takeichi M. Identification of a neural gamma-catenin as a key regulator of cadherin function and multicellular organization. Cell 1992;70:293-301.
24. Moretti S, Pinzi C, Spallanzani A, et al. Immunohistochemical evidence of cytokine networks during progression of human melanocytic lesions. Int J Cancer 1999;84:160-8.
25. Nesbit M, Herlyn M. Adhesion receptors in human melanoma progression. Invasion Metastasis 1994;95:131-46.
26. Danen EH, de-Vries TJ, Morandini R, et al. E-cadherin expression in human melanoma. Melanoma Res 1996;6:127-31.
27. Vleminckx K, Vakaet L, Jr Mareel Vleminckx K, Vakaet L, Jr Mareel, Fiers W, Van Roy F. Genetic manipulation of E-cadherin expression by epithelial tumour cells reveals an invasion suppressor role. Cell 1991;66:107-19.
28. Frixen UH, Behrens J, Sachs M, et al. E-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells. J Cell Biol 1991;113:173-85.
29. Moretti S, Spallanzani A, Amato L. Vitiligo and epidermal microenvironment: possible involvement of keratinocyte-derived cytokines. Arch Dermatol 2002;138:273-4.
30. Fnasaka Y, Chakraborty AK, Hayashi Y, et al. Modulation of melanocyte-stimulating hormone receptor expression on normal human melanocytes: evidence for regulatory role of ultraviolet B, interleukin-1 alpha, interleukin-1 beta, endothelin-1 and tumour necrosis factor-alpha. Br J Dermatol 1998;139:216-24.
31. Martinez-Esparza M, Solano F, Garcia-Borron JC. Independent regulation of tyrosinase by the hypopigmenting cytokines TGF beta1 and TNF alpha and the melanogenic hormone alpha-MSH in B16 mouse melanocytes. Cell Mol Biol 1999;45:991-1000.